Assessment of the influence of fatty acids on indices of insulin sensitivity and myocellular lipid content by use of magnetic resonance spectroscopy in cats

American Journal of Veterinary Research

Volumn 65, Issue 8, 2004, Pages 1090-1099

  Wilkins, Caroline ^a   Long Jr , Robert C ^b   Waldron, Mark ^c   Ferguson, Duncan C ^a   Hoenig, Margarethe ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLEARANCE; CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; FATTY ACID BLOOD LEVEL; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LEAN BODY WEIGHT; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID STORAGE; MUSCLE CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALIA; FELIS CATUS;

EID: 4344620853     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.1090     Document Type: Article

References (64)

1. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001;104:531-543.
2. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001;60:329-339.
3. Rajala MW, Scherer PE. Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003;144:3765-3773.
4. DeFronzo RA, Ferranini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obeity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14:173-194
5. Porte D Jr. β-cells in type II diabetes mellitus. Diabetes 1991;40:166-180.
6. Lichtenstein AH, Kennedy E, Barrier P, et al. Dietary fat consumption and health. Nutr Rev 1998;56:S3-S19.
7. Feskens EMJ, Loeber JG, Kromhout D. Diet and physical activity as determinants of hyperinsulinemia: the Zutphen elderly study. Am J Epidemiol 1994;140:350-360.
8. Storlien LH, Baur LA, Kriketos AD, et al. Dietary fats and insulin action. Diabetologia 1996;39:621-631.
9. Summers LK, Fielding BA, Bradshaw HA, et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal distribution and improves insulin sensitivity. Diabetologia 2002;45:369-377.
10. Dobbins RL, Szczepaniak LS, Myhill J, et al. The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes 2002;51:1825-1833.
11. Storlien LH, Higgins JA, Thomas TC, et al. Diet composition and insulin action in animal models. Br J Nutr 2000;83:S85-S90.
12. Clarke SD. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. BrJ Nutr 2000;83(suppl 1:S59-S66.
13. Sirtori CR, Galli C. N-3 fatty acids and diabetes. Biomed Pharmacother 2002;56:397-406.
14. Chicco A, D'Alessandro ME, Karabatas L, et al. Effect of moderate levels of dietary fish oil on insulin secretion and sensitivity, and pancreas insulin content in normal rats. Ann Nutr Metab 1996;40:61-70.
15. Rustan AC, Nenseter MS, Drevon CA. Omega-3 and omega-6 fatty acids in the insulin resistance syndrome. Lipid and lipoprotein metabolism and atherosclerosis. Ann N Y Acad Sci 1997;827:310-326.
16. Jucker BM, Cline GW, Barucci N, et al. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle. Diabetes 1999;48:134-140.
17. Kelley DE, Goodpaster BH, Storlien L. Muscle triglyceride and insulin resistance. Annu Rev Nutr 2002;22:325-346.
18. Perseghin G, Scifo P, De Cobelli F, et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999; 48:1600-1606.
19. Jacob S, Machann J, Rett K, et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 1999;48:1113-1119.
20. McGarry JD. Banting Lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51:7-18.
21. Hoenig M, Ferguson DC. Impairment of glucose tolerance in hyperthyroid cats. J Endocrinol 1989;121:249-251.
22. Hoenig M, Ferguson DC. The diagnostic utility of glycosylated hemoglobin in the cat. Domest Anim Endocrinol 1999;16:11-17.
23. Hoenig M, Wilkins C, Holson JC, et al. Effects of obesity on lipid profiles in neutered male and female cats. Am J Vet Res 2003; 64:299-303.
24. Boesch C, Kreis R. Dipolar coupling and ordering effects observed in magnetic resonance spectra of skeletal muscle. NMR Biomed 2001;14:140-148.
25. Bottomley PA. Selective volume method for performing localized NMR spectroscopy. Fairfield, Conn: General Electric Co. US patent 4,480,228. October 30, 1984.
26. Pellizzon M, Buison A, Ordiz F, et al. Effects of dietary fatty acids and exercise on body-weight regulation and metabolism in rats. Obes Res 2002;10:947-955.
27. Couet C, Delarue J, Ritz P, et al. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord 1997;21:637-643.
28. Jensen MD, Haymond MW, Rizza RA, et al. influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989;83:1168-1173.
29. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity Diabetes 2000;49:883-888.
30. Nagy K, Levy J, Grunberger G. High-fat feeding induces ussue-specific alteration in proportion of activated insulin receptors in rats. Acta Endocrinol 1990;122:361-368.
31. de Deckere EA, Korver O, Verschuren PM, et al. Health aspects of fish and n-3 polyunsaturated fatty acids from plant and marine origin. Eur J Clin Nutr 1998;52:749-753.
32. Nelson RW, Himsel CA, Feldman EC, et al. Glucose tolerance and insulin response in normal-weight and obese cats. Am J Vet Res 1990;51:1357-1362.
33. Hoenig M, Alexander S, Holson J, et al. Influence of glucose dosage on interpretation of intravenous glucose tolerance tests in lean and obese cats. J Vet Intern Med 2002;16:529-532.
34. Biourge V, Nelson RW, Feldman EC, et al. Effect of weight gain and subsequent weight loss on glucose tolerance and insulin response in healthy cats. J Vet Intern Med 1997;11:86-91.
35. Stein DT, Stevenson BE, Chester MW, et al. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 1997;100:398-403.
36. Appleton DJ, Rand JS, Sunvold GD. Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain. J Feline Med Surg 2001;3:211-228.
37. Hoenig M, Ferguson DC. Effect of darglitazone on glucose clearance and lipid metabolism in obese cats. Am J Vet Res 2003; 64:1409-1413.
38. Reaven GM. Importance of identifying the overweight patient who will benefit the most by losing weight. Ann Intern Med 2003; 138:420-423.
39. Shi Y, Taylor SI, Tan SL, et al. When translation meets metabolism: multiple links to diabetes. Endocr Rev 2003;24:91-101.
40. Chan CB, MacDonald PE, Saleh MC, et al. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 1999;48:1482-1486.
41. Chambrier C, Bastard JP, Ricusset J, et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor γ. Obes Res 2002;210:518-525.
42. Brennan CL, Ferguson DC, Hoenig M. GLUT4 but not GLUT1 expression decreases early in the development of feline obesity. Domest Anim Endocrinol 2004;26:291-301.
43. Ploug T, Ralston E. Anatomy of glucose transporters in skeletal muscle. Effects of insulin and contractions. Adv Exp Med Biol 1998;441:17-26.
44. Shulman G. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171-176.
45. Ranganath L, Norris F, Morgan L, et al. The effect of circulating non-esterified fatty acids on the entero-insular axis. Eur J Clin Invest 1999;29:27-32.
46. Mingrone G, DeGaetano A, Greco AV, et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 1997;40:599-605.
47. Kraegen EW, Clark PW, Jenkins AB, et al. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991;40:1397-1403.
48. Storlien LH, Jenkins AB, Chisholm DJ, et al. Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991;40:280-289.
49. Luo J, Rizkalla SW, Vidal H, et al. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study Diabetes Care 1998;21:717-724.
50. Harris WS. N-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 1996; 31:243-252.
51. Golay A, Swislocki AL, Chen YD, et al. Effect of obesity on ambient plasma glucose, free fatty acids, insulin, growth hormone and glucagons concentrations. J Clin Endocrinol Metab 1986;63:481-484.
52. Sadur CN, Yost TJ, Eckel RH. Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity. J Clin Endocrinol Metab 1984;59:1176-1182.
53. Campbell PJ, Carlson MG, Nurjhan N. Fat metabolism in human obesity Am J Physiol 1994;266:E600-E605.
54. Lewis GF, Carpentier A, Adeli K, et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23:201-229.
55. Yost TJ, Froyd KK, Jensen DR, et al. Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in noninsulin-dependent diabetes mellitus. Metabolism 1995;44:786-790.
56. Howard BV. Insulin resistance and lipid metabolism. Am J Cardiol 1999;84:28J-32J.
57. Yamashita S, Nakamura T, Shimomura I, et al. Insulin resistance and body fat distribution. Diabetes Care 1996;19:287-291.
58. Szabo J, Ibrahim WH, Sunvold GD, et al. Influence of dietary protein and lipid on weight loss in obese ovariohysterectomized cats. Am J Vet Res 2000;61:559-565.
59. Dimski DS, Buffington CA, Johnson SE, et al. Serum lipoprotein concentrations and hepatic lesions in obese cats undergoing weight loss. Am J Vet Res 1992;53:1259-1262.
60. Hennig J. The application of phase rotation for localized in-vivo proton spectroscopy with short echo times. J Magn Reson 1992;96:40-49.
61. 1H nuclear magnetic resonance spectroscopy in lean and obese adolescents. Diabetes 2002;51:1022-1027.
62. Greco AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002;51:144-151.
63. Bachmann OP, Dahl DB, Brechtel K, et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 2001; 50:2579-2584.
64. Boden G, Lebed B, Schatz M, et al. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001;50:1612-1617.